39 · Utentes com diabetes com última HbA1c controlada

Normas em que o indicador assenta

• American Diabetes Association. Standards of Care in Diabetes—2026: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises (2026)
  ▸ Fonte: American Diabetes Association. Standards of Care in Diabetes—2026: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises · Recomendação 6.3a

  «6.3a An A1C goal of <7% (<53 mmol/mol) is appropriate for many nonpregnant adults without severe hypoglycemia or hypoglycemia affecting health or quality of life. A»

  https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/ ↗
• American Diabetes Association. Standards of Care in Diabetes—2026: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises (2026)
  ▸ Fonte: American Diabetes Association. Standards of Care in Diabetes—2026: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises · Recomendação 6.5

  «6.5 Less stringent glycemic goals may be appropriate for individuals with significant cognitive and/or functional limitations, frailty, or severe comorbidities or where the harms of treatment, including hypoglycemia, are greater than the benefits. B»

  https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/ ↗

Normas, guidelines e documentos oficiais

• A norma atual recomenda desintensificar insulina, sulfonilureias ou meglitinidas quando exista risco elevado de hipoglicemia, dentro de objetivos individualizados.
  ▸ Fonte: American Diabetes Association. Standards of Care in Diabetes—2026 · Recomendação 6.6

  «6.6 Deintensify hypoglycemia-causing medications (insulin, sulfonylureas, or meglitinides), or switch to a medication class with lower hypoglycemia risk, for individuals who are at high risk for hypoglycemia, within individualized glycemic goals. B»

  https://pmc.ncbi.nlm.nih.gov/articles/PMC12690178/ ↗